WebAmerican Heart Association WebAssign to statin treatment group; use ASCVD risk estimator plus. In lower risk primary prevention adults 40-75 years with LDL-C ≥70 mg/dL (≥1.8 mmol/L) . Not needed in secondary prevention, LDL-C ≥190 mg/dL (≥4.9 mmol/L) and those 40-75 years with diabetes. Assess other patient characteristics which influence risk.

The 2024 …

WebDec 15, 2024 · All patients with DM (age 40-75) with LDL-C 70-189, without known CVD, should receive moderate-intensity statin, or if 10-year risk by ASCVD risk calculator is > 7.5%, high-intensity statin. Patients age 40-75 without diabetes or CVD, but with LDL-C 70-189 and 10-year risk >7.5%, should consider a moderate-to-high intensity statin. WebIn 2016, an expert consensus panel from the ACC recommended the use of nonstatin therapies (ezetimibe and PCSK9 inhibitors) in addition to maximally tolerated statin therapy in individuals whose LDL-cholesterol and non-HDL-cholesterol levels remained above certain thresholds after statin treatment. convert weighted average mark to gpa

High and Moderate- Intensity Statin Table - Pharmacy Quality

WebSep 12, 2024 · US guideline: Diabetics 40-75 years of age and an LDL-C level of ≥70 mg/dl, regardless of estimated 10-year ASCVD risk, start moderate-intensity statins. In T2DM at higher risk, especially those with multiple risk factors or those 50-75 years of age, it is reasonable to use a high-intensity statin to reduce the LDL-C level by ≥50%. WebFeb 17, 2024 · Dosage and intensity: Typical rosuvastatin dosages range from 5 mg to 40 mg daily. The 5 mg and 10 mg doses are considered moderate intensity. Doses from 20 … WebMar 14, 2024 · Patients were divided into 3 groups according to the Japanese standard doses of statins and statin-intensity categories defined by the 2013 American College of … convert weighted gpa to unweighted gpa